CL2010001274A1 - Pharmaceutical combination comprising 3-z- [1- (4- (n - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -n-methyl-amino) anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone and n- [4- [2- (2-amino-4,7-dihydro-4-oxo-1h-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl) benzoyl acid ) -l-glutamic; pharmaceutical kit; and use in cell proliferation diseases - Google Patents

Pharmaceutical combination comprising 3-z- [1- (4- (n - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -n-methyl-amino) anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone and n- [4- [2- (2-amino-4,7-dihydro-4-oxo-1h-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl) benzoyl acid ) -l-glutamic; pharmaceutical kit; and use in cell proliferation diseases

Info

Publication number
CL2010001274A1
CL2010001274A1 CL2010001274A CL2010001274A CL2010001274A1 CL 2010001274 A1 CL2010001274 A1 CL 2010001274A1 CL 2010001274 A CL2010001274 A CL 2010001274A CL 2010001274 A CL2010001274 A CL 2010001274A CL 2010001274 A1 CL2010001274 A1 CL 2010001274A1
Authority
CL
Chile
Prior art keywords
amino
methyl
indolinone
methylcarbonyl
anilino
Prior art date
Application number
CL2010001274A
Other languages
Spanish (es)
Inventor
Frank Hilberg
Rolf Kaiser
Martin Friedrich Stefanic
David Shapiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66221453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2010001274(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of CL2010001274A1 publication Critical patent/CL2010001274A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Combinación farmacéutica que comprende 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-metil-amino)anilino)-1-fenil-metileno]-6-metoxicarbonil-2-indolinona o una sal y el acido n-[4-[2-(2-amino-4,7-dihidro-4-oxo-1h-pirrolo[2,3-d]pirimidin-5-il)etil)benzoil)-l-glutámico o una sal; kit farmacéutico; y uso en enfermedades de proliferación celular.Pharmaceutical combination comprising 3-z- [1- (4- (n - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -n-methyl-amino) anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone or a salt and the acid n- [4- [2- (2-amino-4,7-dihydro-4-oxo-1h-pyrrolo [2,3-d] pyrimidin-5-yl ) ethyl) benzoyl) -l-glutamic acid or a salt; pharmaceutical kit; and use in cell proliferation diseases.

CL2010001274A 2008-06-06 2010-11-19 Pharmaceutical combination comprising 3-z- [1- (4- (n - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -n-methyl-amino) anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone and n- [4- [2- (2-amino-4,7-dihydro-4-oxo-1h-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl) benzoyl acid ) -l-glutamic; pharmaceutical kit; and use in cell proliferation diseases CL2010001274A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08157749 2008-06-06
US7888208P 2008-07-08 2008-07-08

Publications (1)

Publication Number Publication Date
CL2010001274A1 true CL2010001274A1 (en) 2011-05-13

Family

ID=66221453

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2010001274A CL2010001274A1 (en) 2008-06-06 2010-11-19 Pharmaceutical combination comprising 3-z- [1- (4- (n - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -n-methyl-amino) anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone and n- [4- [2- (2-amino-4,7-dihydro-4-oxo-1h-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl) benzoyl acid ) -l-glutamic; pharmaceutical kit; and use in cell proliferation diseases

Country Status (3)

Country Link
BR (1) BRPI0913231A2 (en)
CL (1) CL2010001274A1 (en)
NO (1) NO2985025T3 (en)

Also Published As

Publication number Publication date
NO2985025T3 (en) 2018-06-16
BRPI0913231A2 (en) 2019-08-27

Similar Documents

Publication Publication Date Title
UY30136A1 (en) SPECIFIC SALT, ANHYDRA AND CRYSTALLINE FORM OF A DIHYDROPTERIDION DERIVATIVE
RS54293B1 (en) Pharmaceutical combination
MEP53708A (en) 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition
ATE433979T1 (en) HETEROBICYCLIC PROTEIN KINASE INHIBITORS SUBSTITUTED WITH A 6,6-BICYCLIC RING
CU20110213A7 (en) DISACARINE SALTS, DIFUMARIC ACID, DI-1-HYDROXY-2-NAFTOIC ACID AND MONOBENZOIC ACID OF 2- (4 - ((2-AMINO-4-METHYL-6- (PENTILAMINO) PIRIMIDIN-5-IL) METHYL) ) ACETATE OF 4- (DIMETHYLAMINE) BUTILO
DE60325761D1 (en) DIAMINOTRIAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
SG170785A1 (en) Benzothiazoles having histamine h3 receptor activity
RS51106B (en) Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
CY2016050I1 (en) 4-[[4-[[4-(2-CYANOETHENYL)-2,6-DIMETHYLPHENYL]AMINO]-2-PYRIMIDINYL]AMINO]BENZONITRIUM SALT
EA200800201A1 (en) CRYSTAL FORMS OF 4-METHYL-N- [3- (4-METHILIMIDAZOL-1-IL) -5-TRIFTOROMETHYLPHENYL] -3- (4-Pyridine-3-Ilpyrimidine-2-Ylamino) Benzamide
NO20053569L (en) Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
NO20053356D0 (en) Aminindazole derivatives and their use as kinase inhibitors.
DE602005017135D1 (en) NEW USE OF PDE5 INHIBITORS
UY29952A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE 4- (4-FLUORO-2-METHYL-1H-INDOL-5-ILOXI) -6-METOXI-7- (3- (PIRROLIDIN-1-IL) PROPOXI) QUINAZOLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME , PREPARATION AND USE PROCESSES
ECSP109890A (en) PARTICLES OF A CRTH2 ANTAGONIST
NO20082249L (en) Fused heterocyclic derivative, medicinal composition containing the same and medicinal use thereof
AR065797A1 (en) USES AND DERIVATIVES OF 1- (2- (2,4- DIMETILFENILSULFANIL) PHENYL) PIPERAZINE
CL2011003138A1 (en) N- (protected- n- (3-methoxy-5-methylpyrazon-2-yl) -2- (4- [1,3,4-oxadiazol-2-yl] phenyl) pyridine-3-sulfonamide and its process of preparation.
SMT201300108B (en) New compositions of 1-Ä2- (2,4-dimethylphenyl sulfanil) -phenylÜ piperazine
ATE538125T1 (en) NEW 2-AZAINDOLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE AS KINASE INHIBITORS
DE602004027354D1 (en) SUBSTITUTED 8y-PYRIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ON AND 8y-PYRIMIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ONDERIVATES AND THEIR USE IN NEURODEEGENERATIVE DISEASES
HRP20080447T3 (en) 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof
NO20025123D0 (en) Water-silica suspensions for use in well cement
NO20043580L (en) Quinazolinone derivatives and their use as CB agonists
NL2000291A1 (en) 1- (1- (2-ethoxyethyl) -3-ethyl-7- (4-methylpyridin-2-ylamino) -1 H -pyrazole [4,3-d] pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof.